awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47103348-81A5FD5E-1FC3-49FA-9A33-39AF8B661646
Q47103348-81A5FD5E-1FC3-49FA-9A33-39AF8B661646
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47103348-81A5FD5E-1FC3-49FA-9A33-39AF8B661646
ERK inhibition sensitizes CZ415-induced anti-osteosarcoma activity in vitro and in vivo.
P2860
Q47103348-81A5FD5E-1FC3-49FA-9A33-39AF8B661646
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47103348-81A5FD5E-1FC3-49FA-9A33-39AF8B661646
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
16792518d638bf4aa2b1f0ccb0f18b2937832aea
P2860
Current development of the second generation of mTOR inhibitors as anticancer agents.